ATE307676T1 - Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region - Google Patents

Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region

Info

Publication number
ATE307676T1
ATE307676T1 AT98930657T AT98930657T ATE307676T1 AT E307676 T1 ATE307676 T1 AT E307676T1 AT 98930657 T AT98930657 T AT 98930657T AT 98930657 T AT98930657 T AT 98930657T AT E307676 T1 ATE307676 T1 AT E307676T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
drug administration
olfactory region
packaging unit
human
Prior art date
Application number
AT98930657T
Other languages
English (en)
Inventor
Sveinbjoern Gizurarson
Original Assignee
Sveinbjoern Gizurarson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE307676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sveinbjoern Gizurarson filed Critical Sveinbjoern Gizurarson
Application granted granted Critical
Publication of ATE307676T1 publication Critical patent/ATE307676T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
AT98930657T 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region ATE307676T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region

Publications (1)

Publication Number Publication Date
ATE307676T1 true ATE307676T1 (de) 2005-11-15

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930657T ATE307676T1 (de) 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region

Country Status (10)

Country Link
US (1) US6647980B1 (de)
EP (1) EP0991479B1 (de)
AT (1) ATE307676T1 (de)
AU (1) AU739893B2 (de)
CA (1) CA2298596A1 (de)
DE (1) DE69832070T2 (de)
DK (1) DK0991479T3 (de)
ES (1) ES2255165T3 (de)
IS (1) IS4516A (de)
WO (1) WO1999001229A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
ATE359099T1 (de) * 2001-02-08 2007-05-15 Nasaleze Patents Ltd Gerät zur ausgabe von pulverförmigem material
JP2005519075A (ja) * 2002-02-25 2005-06-30 リフジャスロウン エイチエフ 吸収促進剤
NZ535873A (en) 2002-05-09 2006-07-28 Glaxo Group Ltd A fluid dispensing device
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
PL1699512T3 (pl) * 2003-11-03 2012-11-30 Glaxo Group Ltd Urządzenie do dozowania płynów
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
JP2009517184A (ja) * 2005-11-29 2009-04-30 アルザ・コーポレーシヨン 嗅覚部位に物質を送達するための鼻用送達装置
WO2007083073A1 (en) * 2006-01-19 2007-07-26 Optinose As Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
BRPI0811071A2 (pt) * 2007-05-04 2014-09-23 The Procter & Gamble Company Produtos, composições microbicidas, e métodos de uso
ES2648196T3 (es) 2008-02-07 2017-12-29 The University Of Washington Dispositivo aerosol circunferencial
WO2010134804A1 (en) 2009-05-19 2010-11-25 Lerner Eduard N Device and methods for enhanced multi-delivery of biologically active substances into an organism and to prevent local irritation
EP4088769A1 (de) 2011-03-03 2022-11-16 Impel Pharmaceuticals Inc. Vorrichtung für nasale arzneimittelabgabe
JP6645735B2 (ja) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド 鼻薬送達用ノズル
CA2909954C (en) 2013-04-28 2021-03-23 Impel Neuropharma, Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
MA42708A (fr) 2015-09-10 2018-07-04 Impel Neuropharma Inc Dispositif d'administration nasale en ligne
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
EP3713628A4 (de) 2017-11-21 2021-08-18 Impel Neuropharma Inc. Intranasale vorrichtung mit tauchrohr
KR20200118032A (ko) 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달
AU2019205329B2 (en) 2018-01-05 2023-04-20 Impel Pharmaceuticals Inc. Intranasal delivery of olanzapine by precision olfactory device
WO2020018959A1 (en) 2018-07-19 2020-01-23 Impel Neuropharma, Inc. Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
CN113473967B (zh) 2019-01-03 2022-09-09 英倍尔制药公司 经鼻药物递送装置
KR20220010011A (ko) 2019-05-17 2022-01-25 임펠 뉴로파마 인코포레이티드 일회용 비강 전달 장치
WO2021048638A1 (en) * 2019-09-13 2021-03-18 Janssen Pharmaceuticals, Inc. Intranasal administration of esketamine
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
ATE156704T1 (de) 1989-12-05 1997-08-15 Ramsey Foundation Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) * 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) * 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
WO1997016181A1 (en) 1995-11-03 1997-05-09 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
IS4516A (is) 1999-01-02
DK0991479T3 (da) 2006-03-13
EP0991479B1 (de) 2005-10-26
US6647980B1 (en) 2003-11-18
DE69832070T2 (de) 2006-07-13
DE69832070D1 (de) 2005-12-01
ES2255165T3 (es) 2006-06-16
CA2298596A1 (en) 1999-01-14
AU739893B2 (en) 2001-10-25
WO1999001229A1 (en) 1999-01-14
AU8102298A (en) 1999-01-25
EP0991479A1 (de) 2000-04-12

Similar Documents

Publication Publication Date Title
DE69832070D1 (de) Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
Tartara et al. Vigabatrin in the treatment of epilepsy: a double‐blind, placebo‐controlled study
NO20001087D0 (no) Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer
DE69527842D1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
EP1242013A4 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
DE69306379D1 (de) Inhalierbare arzneimittel
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
KR20010021505A (ko) 발기 부전을 치료하기 위한 요힘빈 및 아르기닌 함유 약제
KR930019224A (ko) 유산 위험 치료제
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
HUP0301408A2 (hu) Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására
CA3178758A1 (en) Treatment of adjustment disorders
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
RU97116821A (ru) Способ лечения респираторных заболеваний
TH66360A3 (th) องค์ประกอบและวิธีการเกี่ยวกับการรักษาโรคภูมิแพ้
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0991479

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked